Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut R Maecke

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Nuclear Medicine Review. Central & Eastern Europe|August 2, 2016
Radiopharmaceuticals for somatostatin receptor imagingRenata Mikołajczak, Helmut R Maecke
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2012
Radiopharmaceutical development of radiolabelled peptidesMelpomeni Fani, Helmut R Maecke
Metal Ions in Biological Systems|June 23, 2004
Radiometallo-labeled peptides in tumor diagnosis and therapyMihaela Ginj, Helmut R Maecke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand ApplicationsJean Claude Reubi, Helmut R Maecke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
Peptide-based probes for cancer imagingJean Claude Reubi, Helmut R Maecke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2011
Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatmentHelmut R Maecke, Jean Claude Reubi
Anticancer Research|March 9, 2012
Receptor affinity and preclinical biodistribution of radiolabeled somatostatin analogsMilan Laznicek, Alice Laznickova, Helmut R Maecke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
(68)Ga-labeled peptides in tumor imagingHelmut R Maecke, Michael Hofmann, Uwe Haberkorn
Contrast Media & Molecular Imaging|April 3, 2008
68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticalsMelpomeni Fani, João P André, Helmut R Maecke
Anticancer Research|June 3, 2006
Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumorsFlavio Forrer, Christian Waldherr, Helmut R Maecke, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Nuclear Medicine Review. Central & Eastern Europe|August 2, 2016
Radiopharmaceuticals for somatostatin receptor imagingRenata Mikołajczak, Helmut R Maecke
European Journal of Nuclear Medicine and Molecular Imaging|March 6, 2012
Radiopharmaceutical development of radiolabelled peptidesMelpomeni Fani, Helmut R Maecke
Metal Ions in Biological Systems|June 23, 2004
Radiometallo-labeled peptides in tumor diagnosis and therapyMihaela Ginj, Helmut R Maecke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 3, 2017
Approaches to Multireceptor Targeting: Hybrid Radioligands, Radioligand Cocktails, and Sequential Radioligand ApplicationsJean Claude Reubi, Helmut R Maecke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 18, 2008
Peptide-based probes for cancer imagingJean Claude Reubi, Helmut R Maecke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 17, 2011
Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatmentHelmut R Maecke, Jean Claude Reubi
Anticancer Research|March 9, 2012
Receptor affinity and preclinical biodistribution of radiolabeled somatostatin analogsMilan Laznicek, Alice Laznickova, Helmut R Maecke
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
(68)Ga-labeled peptides in tumor imagingHelmut R Maecke, Michael Hofmann, Uwe Haberkorn
Contrast Media & Molecular Imaging|April 3, 2008
68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticalsMelpomeni Fani, João P André, Helmut R Maecke
Anticancer Research|June 3, 2006
Targeted radionuclide therapy with 90Y-DOTATOC in patients with neuroendocrine tumorsFlavio Forrer, Christian Waldherr, Helmut R Maecke, et al.
Pageof 9